Zymeworks Inc. · NASDAQ:ZYME
BVF PARTNERS L P/IL reported a 5.20% stake in Zymeworks Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
BVF PARTNERS L P/IL reported a 5.20% stake in Zymeworks Inc., 3,938,641 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 5.20%
- Shares
- 3,938,641
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.70% | 2,045,162 |
| BVF I GP LLC | 2.70% | 2,045,162 |
| BIOTECHNOLOGY VALUE FUND II LP | 2.10% | 1,601,489 |
| BVF II GP LLC | 2.10% | 1,601,489 |
| Biotechnology Value Trading Fund OS LP | 0.30% | 212,898 |
| BVF Partners OS Ltd. | 0.30% | 212,898 |
| BVF GP HOLDINGS LLC | 4.90% | 3,646,651 |
| BVF PARTNERS L P/IL | 5.20% | 3,938,641 |
| BVF INC/IL | 5.20% | 3,938,641 |
| LAMPERT MARK N | 5.20% | 3,938,641 |
Source
Related
- Zymeworks Inc.
- Biotechnology Value Fund L P
- Zymeworks Inc. shareholders
- Form 4 · Schayowitz Adam · Oct 9, 2026
- Form 4 · Hollywood Mark · Jul 6, 2026
- Schedule 13G/A · Rubric Capital Management LP · May 15, 2026
- Schedule 13G · Perceptive Advisors LLC · Apr 15, 2026
- Schedule 13G/A · Rubric Capital Management LP · Feb 13, 2026